Regulation of Sequential Protein Kinase Pathways
Regulation of Sequential Protein Kinase Pathways
批准号:
8038148
负责人:
GARY L. JOHNSON
金额:
$10.14万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2011-03-31
关键词:
AblationAnimalsAntibodiesBackBindingBiological AssayBiological FactorsBiological ModelsBlood VesselsBreast Cancer CellBreast Fat PadCancer cell lineCell CommunicationCell LineCell NucleusCell membraneCell physiologyCellsChromatinChronicComplexCultured CellsDataData SetDatabasesDevelopmentDiseaseEGF geneEndosomesEnhancersExtracellular MatrixFOS geneFamilyFatty acid glycerol estersFibroblastsFocal AdhesionsFundingGene ExpressionGene TargetingGenesGenetic TranscriptionGoalsGrantGranulocyte-Macrophage Colony-Stimulating FactorHomeostasisHumanHypoxiaIL8 geneImage AnalysisImmigrationImmunoblottingIn VitroInflammationInjection of therapeutic agentIschemiaJUN geneLaboratoriesLeast-Squares AnalysisLeft ventricular structureLibrariesLocationLungMAP3K1 geneMAP3K7 geneMAPK11 geneMAPK14 geneMAPK7 geneMAPK8 geneMCF7 cellMEKKsMammalian CellMammary glandMatrix Metalloproteinase InhibitorMatrix MetalloproteinasesMeasurementMeasuresMetalloproteasesMetricMitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesModelingMusNeoplasm MetastasisOutputPathway AnalysisPathway interactionsPeptide HydrolasesPhenotypePhosphotransferasesPhysiologicalPhysiologyPlacentaPlayPrimary NeoplasmPromoter RegionsPropertyProtease GeneProtein FamilyProtein KinaseProteinsRNA InterferenceReceptor GeneRegulationResearch PersonnelRoleSerineSignal PathwaySignal TransductionSiteSmall Interfering RNAStimulusStromal Cell-Derived Factor 1SystemTailTestingThreonineTimeTissuesTranscription Factor AP-1Tumor Cell LineUbiquitinationUnited States National Institutes of HealthUrokinaseUrokinase Plasminogen Activator ReceptorVascular Endothelial Growth FactorsVeinsWorkbasebonecell growthcytokinedrug discoveryfos-related antigen-2human diseasein vivoknockout genemalignant breast neoplasmmatrigelmembermigrationmodel developmentneoplastic cellpromoterprotein expressionreceptorreceptor expressionresearch studyresponsesmall hairpin RNAsoft tissuespatiotemporaltooltranscription factortumortumor progression
中文摘要
丝裂原活化蛋白激酶(MAPK)是丝氨酸-苏氨酸蛋白激酶,其在细胞分裂中起关键作用。
调节细胞内稳态MAPKs是三个激酶中继系统的成员,
MARK、MARK激酶(MKK)和MARK激酶激酶(MKKK)。四个MARK家族,ERK 1/2,p38,JNK和
ERK5是整合的MARK信号网络的成员。有7个MKK,但至少有20个MKKK在
MARK信号网络我们已经通过基因敲除来消除表达,或者通过基因敲入来消除表达。
四种MKKK(MEKK 1、2、3、4)的激酶活性。每种MEKK的消融或激酶抑制导致
小鼠中独特的生理表型。发现不同的MEKKs调节神经形成、血管生成和血管生成。
胎盘!发展和转移过程中的肿瘤细胞的传播,
缺血或缺氧,以及慢性炎症的特定方面。目前提案的假设是
MKKK在对不同刺激的细胞反应中差异地整合了特异性MAPK的激活。
尽管MARK信号网络在细胞和动物生理学中的重要性,
了解不同的MKKK如何协调调节MARK网络以实现细胞内稳态。
我们已经证明,RNAi忠实地再现了细胞中MKKK的靶向基因敲除。因此
定义MKKK的功能,RNAi筛选以消除具有以下特征的8个MKKK的测试集的表达:
特别是在体内平衡控制方面的相关性,将在四种人乳腺癌细胞系中进行。的
该提案的目标将确定:1。MKKK敲低对信号传导的功能性后果
MARK网络的动态。2. MKKKs在ERK 1/2、JNK、p38和p53时空激活中的作用
ERK5。3.了解细胞因子和蛋白酶表达变化的转录机制
由特异性MKKK敲除引起。4.为了分析特异性MKKK敲低对
原位肿瘤细胞生长和转移。5.从这些数据中,基于偏最小二乘的多变量模型
将开发方块来定义特定MKKK在控制信令网络中的功能,
生理输出。这种系统级模型的创建,沿着着模型之间的迭代循环
和实验,将允许我们定义特定MKKK在控制信令网络中的功能
与肿瘤细胞表型相关,包括转移相关的生理输出。
英文摘要
Mitogen activated protein kinases (MAPKs) are serine-threonine protein kinases that play critical roles in
regulating cellular homeostasis. MAPKs are members of a three kinase relay system composed of the
MARK, MARK kinase (MKK) and MARK kinase kinase (MKKK). Four MARK families, ERK1/2, p38, JNK and
ERK5 are members of an integrated MARK signaling network. There are 7 MKKs but at least 20 MKKKs in
the MARK signaling network. We have made gene knockouts to ablate expression or knockins to inactivate
the kinase activity of four MKKKs (MEKK1, 2, 3, 4). Ablation or kinase inhibition of each MEKK results in a
unique physiological phenotype in the mouse. Different MEKKs were found to regulate neurulation, vascular
and placenta! development, and dissemination of tumor cells during metastasis, tissue remodelingfollowing
ischemia or hypoxia, and specific aspects of chronic inflammation. The hypothesis of the current proposal is
that MKKKs differentially integrate the activation of specific MAPKs in cellular responses to diverse stimuli.
Despite the importance of MARK signaling networks in cell and animal physiology there is no comprehensive
understanding of how different MKKKs coordinately regulate the MARK network for cellular homeostasis.
We have shown that RNAi faithfully recapitulates targeted gene knockout of MKKKs in cells. Therefore,to
define the function of MKKKs, an RNAi screen to ablate expression of a test set of 8 MKKKs that have
particular relevance in control of homeostasis, will be performed in four human breast cancer cell lines. The
aims of the proposal will define: 1. The functional consequence of MKKK knockdown on the signaling
dynamics of the MARK network. 2. Role of MKKKs in the spatiotemporal activation of ERK1/2, JNK, p38 and
ERK5. 3. To understand the transcriptional mechanism for changes in cytokine and protease expression
resulting from specific MKKK knockdown. 4. To analyze the consequence of specific MKKK knockdown on
orthotopic tumor cell growth and metastasis. 5. From these data a multivariate model based on Partial Least
Squares will be developed to define the function of specific MKKKs in controlling signaling networks and
physiological outputs. The creation of this systems-level model, along with iterative cycling between model
and experiment, will allow us to define the function of specific MKKKs in controlling signaling networks
related to tumor cell phenotype including metastasis-related physiological outputs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Illuminating Function of the Understudied Druggable Kinome
-
批准号:10251291
-
项目类别:
-
资助金额:$225.18万
-
财政年份:2017
-
负责人:GARY L. JOHNSON
-
依托单位:
Illuminating Function of the Understudied Druggable Kinome
-
批准号:9762097
-
项目类别:
-
资助金额:$226.6万
-
财政年份:2017
-
负责人:GARY L. JOHNSON
-
依托单位:
Illuminating Function of the Understudied Druggable Kinome
-
批准号:9453342
-
项目类别:
-
资助金额:$230.82万
-
财政年份:2017
-
负责人:GARY L. JOHNSON
-
依托单位:
Illuminating Function of the Understudied Druggable Kinome
-
批准号:10015261
-
项目类别:
-
资助金额:$225.92万
-
财政年份:2017
-
负责人:GARY L. JOHNSON
-
依托单位:
The adaptive kinome in pancreatic cancer
-
批准号:8859584
-
项目类别:
-
资助金额:$57.37万
-
财政年份:2015
-
负责人:GARY L. JOHNSON
-
依托单位:
Activation and Regulation of the Understudied Kinome Using MIB/MS Technology
-
批准号:9120936
-
项目类别:
-
资助金额:$39.51万
-
财政年份:2014
-
负责人:GARY L. JOHNSON
-
依托单位:
Kinome Reprogramming in Response to Targeted Kinase Inhibitors
-
批准号:8457042
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2012
-
负责人:GARY L. JOHNSON
-
依托单位:
Kinome Reprogramming in Response to Targeted Kinase Inhibitors
-
批准号:8273335
-
项目类别:
-
资助金额:$27.89万
-
财政年份:2012
-
负责人:GARY L. JOHNSON
-
依托单位:
Kinome Reprogramming in Response to Targeted Kinase Inhibitors
-
批准号:8607578
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2012
-
负责人:GARY L. JOHNSON
-
依托单位:
Molecular Therapeutics
-
批准号:8340206
-
项目类别:
-
资助金额:$18.8万
-
财政年份:2011
-
负责人:GARY L. JOHNSON
-
依托单位:
Receptor Interaction with GTP-Regulatory Proteins
-
批准号:7867340
-
项目类别:
-
资助金额:$36.32万
-
财政年份:2009
-
负责人:GARY L. JOHNSON
-
依托单位:
Function of MEKK3 and its osmosensing scaffold protein
-
批准号:7889368
-
项目类别:
-
资助金额:$10.38万
-
财政年份:2009
-
负责人:GARY L. JOHNSON
-
依托单位:
Defining Signal Network Plasticity
-
批准号:7498599
-
项目类别:
-
资助金额:$7.32万
-
财政年份:2008
-
负责人:GARY L. JOHNSON
-
依托单位:
EFFICACY OF COORDINATED SUPPORTIVE CARE IN GYNECOLOGIC ONCOLOGY PATIENTS
-
批准号:7608096
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2007
-
负责人:GARY L. JOHNSON
-
依托单位:
EFFICACY OF COORDINATED SUPPORTIVE CARE IN GYNECOLOGIC ONCOLOGY PATIENTS
-
批准号:7378108
-
项目类别:
-
资助金额:$2.08万
-
财政年份:2006
-
负责人:GARY L. JOHNSON
-
依托单位:
Inhibitor Screens for Five MAPK Kinase Kinases Important in Human Disease
-
批准号:7169344
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2006
-
负责人:GARY L. JOHNSON
-
依托单位:
EFFICACY OF COORDINATED SUPPORTIVE CARE IN GYNECOLOGIC ONCOLOGY PATIENTS
-
批准号:7203341
-
项目类别:
-
资助金额:$4.33万
-
财政年份:2005
-
负责人:GARY L. JOHNSON
-
依托单位:
UNC Center for Nanosensing the Stressome (RMI)
-
批准号:6930731
-
项目类别:
-
资助金额:$7.3万
-
财政年份:2004
-
负责人:GARY L. JOHNSON
-
依托单位:
Efficacy of Coordinated Supportive Care in Gynecologic Oncology Patients
-
批准号:6981289
-
项目类别:
-
资助金额:$2.78万
-
财政年份:2004
-
负责人:GARY L. JOHNSON
-
依托单位:
Function of MEKK3 and its osmosensing scaffold protein
-
批准号:8123425
-
项目类别:
-
资助金额:$31.14万
-
财政年份:2003
-
负责人:GARY L. JOHNSON
-
依托单位:
海外基金